ACM
BIO icon

Aquatic Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Aquatic Capital Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$807K Buy
2,749
+2,658
+2,921% +$754K 0.03% 627
2026
Q1 		$25.4K Sell
91
-10,296
-99% -$2.97M ﹤0.01% 1230
2025
Q4 		$3.15M Sell
10,387
-7,037
-40% -$2.2M 0.09% 278
2025
Q3 		$4.89M Buy
17,424
+142
+0.8% +$38.6K 0.09% 269
2025
Q2 		$4.17M Buy
17,282
+9,231
+115% +$2.18M 0.08% 280
2025
Q1 		$1.96M Buy
+8,051
New +$2.42M 0.05% 418
2024
Q3 		– Sell
-20,720
Closed -$5.66M – 1162
2024
Q2 		$5.66M Buy
+20,720
New +$6.03M 0.21% 109
2024
Q1 		– Sell
-24,840
Closed -$8.02M – 1236
2023
Q4 		$8.02M Buy
24,840
+10,000
+67% +$3.13M 0.2% 122
2023
Q3 		$5.32M Buy
14,840
+9,940
+203% +$3.84M 0.22% 119
2023
Q2 		$1.86M Buy
4,900
+2,300
+88% +$936K 0.1% 217
2023
Q1 		$1.25M Buy
+2,600
New +$1.22M 0.08% 245
2022
Q4 		– Sell
-2,700
Closed -$1.13M – 1370
2022
Q3 		$1.13M Buy
+2,700
New +$1.35M 0.11% 242
2022
Q2 		– Sell
-100
Closed -$56K – 1211
2022
Q1 		$56K Buy
+100
New +$60.3K 0.08% 260

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Aquatic Capital Management's BIO Position: Q2 2026 in Review

Aquatic Capital Management increased its Bio-Rad Laboratories Class A (BIO) stake by 2,921% in Q2 2026, buying an estimated $754K and bringing the position to 2,749 shares worth $807K. The position accounts for 0.03% of the portfolio, ranked #627.

Aquatic Capital Management first reported a position in BIO in Q1 2022 and has held it in 13 quarters since. The position peaked at $8.02M in Q4 2023. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Aquatic Capital Management held 2,749 shares of Bio-Rad Laboratories Class A worth $807K as of Q2 2026.
  • Aquatic Capital Management bought 2,658 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $754K.
  • Bio-Rad Laboratories Class A made up 0.03% of Aquatic Capital Management's portfolio in Q2 2026, its #627 holding.
  • Aquatic Capital Management first reported a position in Bio-Rad Laboratories Class A in Q1 2022 and has held it in 13 quarters since.
  • Aquatic Capital Management's Bio-Rad Laboratories Class A position peaked at $8.02M in Q4 2023.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.